Home > Armstrong PW > Pharmaco-invasive Strategy and Dosing of Tenecteplase in STEMI Patients 60 to
Pharmaco-invasive Strategy and Dosing of Tenecteplase in STEMI Patients 60 to <75 Years: An Inter-trial Comparison of the STREAM-1 and STREAM-2 Trials: Comparison of Patients 60 to <75 Years in STREAM-1 and -2.